These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17452084)

  • 21. Metabolic effects of furaldehydes and impacts on biotechnological processes.
    Almeida JR; Bertilsson M; Gorwa-Grauslund MF; Gorsich S; Lidén G
    Appl Microbiol Biotechnol; 2009 Mar; 82(4):625-38. PubMed ID: 19184597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
    Saxelin M
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for the use of probiotic bacteria in the treatment of gastrointestinal diseases in dogs.
    Chrzastowska M; Kander M; Depta A
    Pol J Vet Sci; 2009; 12(2):279-84. PubMed ID: 19645362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of probiotic bacteria for prevention and therapy of allergic diseases: studies in mouse model of allergic sensitization.
    Di Felice G; Barletta B; Butteroni C; Corinti S; Tinghino R; Colombo P; Boirivant M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S130-2. PubMed ID: 18806704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria. Comparison with a probiotic strain.
    Dogi CA; Galdeano CM; Perdigón G
    Cytokine; 2008 Mar; 41(3):223-31. PubMed ID: 18248820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How science will help shape future clinical applications of probiotics.
    Reid G
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S62-6; discussion S144-51. PubMed ID: 18181725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenomics: an updated European Research Agenda.
    Demuth A; Aharonowitz Y; Bachmann TT; Blum-Oehler G; Buchrieser C; Covacci A; Dobrindt U; Emödy L; van der Ende A; Ewbank J; Fernández LA; Frosch M; García-Del Portillo F; Gilmore MS; Glaser P; Goebel W; Hasnain SE; Heesemann J; Islam K; Korhonen T; Maiden M; Meyer TF; Montecucco C; Oswald E; Parkhill J; Pucciarelli MG; Ron E; Svanborg C; Uhlin BE; Wai SN; Wehland J; Hacker J
    Infect Genet Evol; 2008 May; 8(3):386-93. PubMed ID: 18321793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics for the prevention or treatment of allergic diseases.
    Prescott SL; Björkstén B
    J Allergy Clin Immunol; 2007 Aug; 120(2):255-62. PubMed ID: 17544096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of acid resistance in Bifidobacterium: a mechanism for improving desirable traits of potentially probiotic strains.
    Collado MC; Sanz Y
    J Appl Microbiol; 2007 Oct; 103(4):1147-57. PubMed ID: 17897220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics.
    Frick JS; Fink K; Kahl F; Niemiec MJ; Quitadamo M; Schenk K; Autenrieth IB
    Infect Immun; 2007 Jul; 75(7):3490-7. PubMed ID: 17485456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics and prebiotics: immunological and clinical effects in allergic disease.
    Tang ML
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():219-35; discussion 235-8, 251-7. PubMed ID: 19710525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond silencing--engineering applications of RNA interference and antisense technology for altering cellular phenotype.
    Hebert CG; Valdes JJ; Bentley WE
    Curr Opin Biotechnol; 2008 Oct; 19(5):500-5. PubMed ID: 18760358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical indications for probiotics: an overview.
    Goldin BR; Gorbach SL
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S96-100; discussion S144-51. PubMed ID: 18181732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics and mucosal barrier in children.
    Penna FJ; Péret LA; Vieira LQ; Nicoli JR
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):640-4. PubMed ID: 18685462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular chaperones in lactic acid bacteria: physiological consequences and biochemical properties.
    Sugimoto S; Abdullah-Al-Mahin ; Sonomoto K
    J Biosci Bioeng; 2008 Oct; 106(4):324-36. PubMed ID: 19000607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial strategies to overcome insect defences.
    Vallet-Gely I; Lemaitre B; Boccard F
    Nat Rev Microbiol; 2008 Apr; 6(4):302-13. PubMed ID: 18327270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-free protein synthesis: applications in proteomics and biotechnology.
    He M
    N Biotechnol; 2008; 25(2-3):126-32. PubMed ID: 18786663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.